Candel Therapeutics, Inc.

This study is testing a new gene therapy approach for men with intermediate-risk prostate cancer who are scheduled for radiation treatment. The therapy involves injecting a modified virus into the prostate, followed by taking an oral antiviral pill, to try to kill cancer cells an…